[Readings] | Public Enemy | Harper’s Magazine

My personal favorite is Juror 59 who didn’t like him because “he┬ádisrespected the Wu-Tang clan.”

From the jury selection process that took place over three days in June for the trial of Martin Shkreli, an investor and hedge fund founder who is facing eight counts of securities and wire fraud. In 2015, when Shkreli was CEO of Turing Pharmaceuticals, the company raised the price of its drug Daraprim by 5,000 percent.

Source: [Readings] | Public Enemy | Harper’s Magazine